Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $5.01 million. The enterprise value is -$1.07 million.
| Market Cap | 5.01M |
| Enterprise Value | -1.07M |
Important Dates
The last earnings date was Thursday, June 13, 2024, before market open.
| Earnings Date | Jun 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 3.17 million shares outstanding. The number of shares has increased by 2,504.47% in one year.
| Shares Outstanding | 3.17M |
| Shares Change (YoY) | +2,504.47% |
| Shares Change (QoQ) | +114.39% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 4.64% |
| Float | 3.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.47 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.07, with zero debt.
| Current Ratio | 2.07 |
| Quick Ratio | 1.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 279.47 |
Financial Efficiency
Return on equity (ROE) is -205.10% and return on invested capital (ROIC) is -118.43%.
| Return on Equity (ROE) | -205.10% |
| Return on Assets (ROA) | -94.20% |
| Return on Capital (ROIC) | -118.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.73M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $177,724 in taxes.
| Income Tax | 177,724 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.00% in the last 52 weeks. The beta is -1.66, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.66 |
| 52-Week Price Change | -89.00% |
| 50-Day Moving Average | 1.23 |
| 200-Day Moving Average | 2.37 |
| Relative Strength Index (RSI) | 67.49 |
| Average Volume (20 Days) | 5,149,807 |
Short Selling Information
The latest short interest is 341,169, so 10.76% of the outstanding shares have been sold short.
| Short Interest | 341,169 |
| Short Previous Month | 135,527 |
| Short % of Shares Out | 10.76% |
| Short % of Float | 10.47% |
| Short Ratio (days to cover) | 1.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -4.02M |
| Pretax Income | -4.88M |
| Net Income | -6.92M |
| EBITDA | -4.87M |
| EBIT | -4.90M |
| Earnings Per Share (EPS) | -$10.94 |
Balance Sheet
The company has $6.08 million in cash and no debt, giving a net cash position of $6.08 million or $1.92 per share.
| Cash & Cash Equivalents | 6.08M |
| Total Debt | n/a |
| Net Cash | 6.08M |
| Net Cash Per Share | $1.92 |
| Equity (Book Value) | 3.40M |
| Book Value Per Share | 1.07 |
| Working Capital | 3.28M |
Cash Flow
| Operating Cash Flow | -3.50M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.50M |
| FCF Per Share | -$1.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CMND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,504.47% |
| Shareholder Yield | -2,504.47% |
| Earnings Yield | -138.20% |
| FCF Yield | -69.87% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 28, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Nov 28, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |